Specifically, chronic inflammation creates favorable conditions for genome-toxic bacteria (e.g., pks+ Escherichia coli) that adhere to the colonic mucosa and induce host DNA damage, thereby promoting CRC in azoxymethane (AOM)-treated mice. This evidence concerns the gene ARAF and colorectal carcinoma.